Zafgen's (ZFGN) ENDO2016 Presentation Highlights Beloranib's Efficacy - RBC Apr 4, 2016 09:06AM
Zafgen to Participate in Upcoming Investor Conferences Feb 16, 2016 04:05PM
Notable Analyst Rating Changes 1/21: (FIT) (ZFGN) (SPWR) Upgraded; (ERIC) (ALKS) (OIS) Downgraded Jan 21, 2016 10:51AM
Pre-Open Stock Movers 01/21: (ZFGN) (XLNX) (FEYE) Higher; (OGXI) (ALKS) (SLM) Lower (more...) Jan 21, 2016 09:28AM
RBC Capital Upgrades Zafgen (ZFGN) to Outperform Jan 21, 2016 06:41AM


Oct 22, 2015 02:33PM Questions Remain for Zafgen (ZFGN) Following Today's Beloranib Update - RBC
Oct 19, 2015 10:13AM RBC Capital Sees Attractive Risk/Reward in Zafgen (ZFGN)
Oct 15, 2015 07:17AM Zafgen (ZFGN) PT Lowered to $46 at RBC Capital; Discusses Road Ahead for Beloranib
Oct 14, 2015 02:48PM RBC Sees 33% of Zafgen (ZFGN) Death Happening in Placebo Arm; Reiterates 'Outperform' Rating
Oct 14, 2015 01:18PM Zafgen (ZFGN) Worst Case Scenario Avoided, RBC Capital - Bloomberg
Oct 13, 2015 08:05PM Zafgen (ZFGN) Won't Comment on 56% Stock Plunge
Oct 13, 2015 03:18PM Zafgen (ZFGN) Continues Free Fall Into Close Amid Radio Silence
Oct 13, 2015 12:06PM Streetinsider.com's Hot Lunchtime Reads 10/13: (TSLA) (TXMD) (FIG) (ACI)
Oct 13, 2015 10:56AM RBC Capital Discusses Theoretical Scenarios Following Zafgen's (ZFGN) Plunge
Mar 20, 2015 11:06AM Zafgen (ZFGN) PT Lifted to $58 at RBC Capital Despit bestPWS Phase III Being Pushed Out a Bit
Jan 22, 2015 04:42PM RBC Capital Starts Zafgen (ZFGN) at Outperform